Millennium Takeda Oncology CO is categorized under Biological Research in Cambridge, MA and active since 2009.
Millennium Takeda Oncology CO was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Deborah Dunsire, Chief Executive Officer at the company’s single location by writing to 40 Landsdowne St, Cambridge, Massachusetts MA 02139 or by phoning (617) 679-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Millennium Takeda Oncology CO |
Contact Person: | Deborah Dunsire, Chief Executive Officer |
Address: | 40 Landsdowne St, Cambridge, Massachusetts 02139 |
Phone Number: | (617) 679-7000 |
Website Address: | millennium.com |
Annual Revenue (USD): | Unknown |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Biological Research |
SIC Code: | 8731 |
NAICS Code: | 5417110 |
Share This Business: |
Millennium Takeda Oncology CO was started in 2009 to provide professional Biological Research under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Deborah Dunsire, Chief Executive Officer for inquiries that concern Millennium Takeda Oncology CO by calling the company number (617) 679-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Millennium Takeda Oncology CO can be found at the coordinates 42.360155,-71.101025 as well as the street address 40 Landsdowne St in Cambridge, Massachusetts 02139.
For its online presence, you may visit Millennium Takeda Oncology CO’s website at millennium.com and engage with its social media outlets through on Twitter and on Facebook.